You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MTD

Showing 1 - 25 of 8,801
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Huntersville, Cleveland (2X-121 and dovitinib)

Recruiting
  • Advanced Solid Tumors
  • 2X-121 and dovitinib
  • Huntersville, North Carolina
  • +1 more
Feb 1, 2023

Amyotrophic Lateral Sclerosis Trial in Hualien City (HK-001, Placebo control)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • Hualien City, Taiwan
    Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Jan 16, 2023

Heart Failure Trial (SGLT2i, beta blocker, ARNI, MRA, MTD, Education-First)

Not yet recruiting
  • Heart Failure
  • SGLT2i, beta blocker, ARNI, MRA, MTD
  • Education-First
  • (no location specified)
Feb 9, 2023

Advanced Solid Tumor Trial in Chengdu (CM350_group 1, CM350_group 2, CM350_group 3)

Recruiting
  • Advanced Solid Tumor
  • CM350_group 1
  • +11 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jun 6, 2022

Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)

Recruiting
  • Sarcoma, Clear Cell
  • CPI-613 + Hydroxychloroquine
  • Duarte, California
  • +7 more
Nov 10, 2022

Safety Issues, Efficacy, MTD Trial in Jilin (Sintilimab 200mg+MB07133 600mg)

Recruiting
  • Safety Issues
  • +2 more
  • Sintilimab 200mg+MB07133 600mg
  • Jilin, Changchun, China
    The First Hospital of Jilin University
Nov 17, 2023

Newly Diagnosed Glioblastoma Multiforme Trial (SI-053)

Not yet recruiting
  • Newly Diagnosed Glioblastoma Multiforme
  • (no location specified)
Apr 4, 2022

Metastatic Colorectal Cancer Trial in Taoyuan (TSB-9-W1)

Completed
  • Metastatic Colorectal Cancer
  • Taoyuan, Taiwan
    Chang Gung Medical Foundation
Mar 21, 2022

Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
May 17, 2023

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Opiate Withdrawal Syndrome Trial in Manchester, London (DMX-1002, Placebo)

Recruiting
  • Opiate Withdrawal Syndrome
  • Manchester, Greater Mancherster, United Kingdom
  • +1 more
Jul 29, 2022

Advanced Solid Tumor Trial in Shanghai (TJ210001 Injection)

Recruiting
  • Advanced Solid Tumor
  • TJ210001 Injection
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Jun 24, 2022

Muscle Tension Dysphonia Trial in Nottingham (Complete Vocal Technique Voice Therapy)

Recruiting
  • Muscle Tension Dysphonia
  • Complete Vocal Technique Voice Therapy
  • Nottingham, Nottinghamshire, United Kingdom
    Nottingham University Hospitals NHS Trust
May 6, 2022

Maxillary Transverse Deficiency (MTD) Trial in Turin (Invisalign® First Phase I treatment (Align Technology, Inc., Santa Clara,

Completed
  • Maxillary Transverse Deficiency (MTD)
  • Invisalign® First Phase I treatment (Align Technology, Inc., Santa Clara, CA, USA)
  • Tooth-borne Hyrax-type maxillary expander
  • Turin, Italy
    University of Turin
May 18, 2022

Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,

Not yet recruiting
  • Recurrent Bladder Carcinoma
  • +2 more
  • Pharmacokinetic Study
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Mantle Cell Lymphoma Trial in Duarte, Ann Arbor, Columbus (Venetoclax, Lenalidomide, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Duarte, California
  • +2 more
Oct 18, 2022

Digestive System Disease Trial in Anaheim (PvP001 , PvP001 100 mg, PvP001 300 mg)

Completed
  • Digestive System Disease
  • PvP001 placebo
  • +11 more
  • Anaheim, California
    Anaheim Clinical Trials
Feb 4, 2022

Malignant Solid Tumour Trial in Santa Monica (INNO-206)

Completed
  • Malignant Solid Tumour
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

Chemo-refractory Colorectal Carcinoma Trial in Hamburg, Ulm (Maximum tolerated dose, MTD: D,L-methadone HCl (Methasan® 10

Recruiting
  • Chemo-refractory Colorectal Carcinoma
  • Maximum tolerated dose, MTD: D,L-methadone hydrochloride (Methasan® 10 mg/ml)
  • Hamburg, Germany
  • +1 more
Apr 21, 2022

Advanced Soft-tissue Sarcoma Trial in Santa Monica (Camsirubicin)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Center
Sep 16, 2021

Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500

Recruiting
  • Pancreas Adenocarcinoma
  • CPI-613® (Dose level -1.0 250 mg/m^2)
  • +6 more
  • Detroit, Michigan
  • +1 more
Nov 9, 2022

AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

Not yet recruiting
  • AL Amyloidosis
  • Venetoclax Oral Tablet, 200 mg
  • +9 more
  • New York, New York
    New York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (MPT0B640)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 25, 2021

Pancreatic Tumor Trial in Korea, Republic of, Taiwan, United States (Antroquinonol)

Active, not recruiting
  • Pancreatic Neoplasm
  • Tampa, Florida
  • +8 more
Aug 16, 2022

Basal Cell Carcinoma Trial in Aventura (Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing

Terminated
Has Results
  • Basal Cell Carcinoma
  • Placebo-containing MNA
  • +4 more
  • Aventura, Florida
    The Center for Clinical and Cosmetic Research
Aug 16, 2022